DDW Events: SLAS2023 Episode 4

<p class="MsoNormal" style="line-height: 150%;"><span style= "font-size: 12pt;"><span style= "line-height: 150%; font-family: Arial, sans-serif;">Ahead of this year’s SLAS2023 conference in San Diego (which takes place 25 February – 1 March) DDW’s Megan Thomas narrates articles from the DDW</span> <a href= "https://www.ddw-online.com/exclusive-ddw-slas2023-supplement-out-now-21546-202301/"> <span style= "line-height: 150%; font-family: Arial, sans-serif;">SLAS2023 supplement</span></a> <span style= "line-height: 150%; font-family: Arial, sans-serif;">as part of the</span> <a href= "https://www.ddw-online.com/t/ddw-events-podcast/"><span style= "line-height: 150%; font-family: Arial, sans-serif;">DDW Events podcast series</span></a><span style= "line-height: 150%; font-family: Arial, sans-serif;">.</span></span></p> <p class="MsoNormal"><span style="font-size: 12pt;">This is episode four, <em>How machine learning and lab automation are changing the future of protein therapeutics</em>. In this article, Kristen Hopson, Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yup Liu, Associate Director, HTS at Generate Biomedicines, reflect on the impact of AI, ML cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research.</span></p>